Cervical cancer
(Redirected from Carcinoma of the cervix)
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
Malignancy of the cervix
Cervical cancer | |
---|---|
![]() | |
Synonyms | N/A |
Pronounce | |
Field | Oncology, Gynecology |
Symptoms | Vaginal bleeding, pelvic pain, dyspareunia |
Complications | Metastasis, kidney failure, pelvic pain, fistula formation |
Onset | |
Duration | |
Types | N/A |
Causes | Human papillomavirus (HPV) infection |
Risks | Multiple sexual partners, smoking, immunosuppression, oral contraceptive use, multiparity |
Diagnosis | Pap smear, Colposcopy, Biopsy, HPV DNA test |
Differential diagnosis | Endometrial cancer, Vaginal cancer, Cervicitis |
Prevention | HPV vaccine, Regular screening, Safe sex practices |
Treatment | Surgery, Radiotherapy, Chemotherapy, Targeted therapy |
Medication | N/A |
Prognosis | Good if detected early; poor in advanced stages |
Frequency | Second most common cancer in women worldwide |
Deaths | High mortality in low-resource countries |
Cervical cancer is a malignancy of the cervix, the lower part of the uterus that connects to the vagina. It is the fourth most common cancer in women globally. Persistent infection with high-risk types of human papillomavirus (HPV), particularly types 16 and 18, is the leading cause. Early detection through screening and HPV vaccination has significantly reduced incidence and mortality in many countries.
Signs and Symptoms[edit | edit source]
In early stages, cervical cancer may present without symptoms. As the disease progresses, it may cause:
- Vaginal bleeding — postcoital, intermenstrual, or postmenopausal
- Pelvic pain — persistent or related to intercourse
- Dyspareunia — painful sexual intercourse
- Foul-smelling vaginal discharge
- Urinary or rectal symptoms in advanced stages due to local invasion
Causes and Risk Factors[edit | edit source]
The primary cause of cervical cancer is persistent infection with high-risk HPV strains. Contributing risk factors include:
- Early sexual activity
- Multiple sexual partners
- Smoking
- Long-term oral contraceptive use
- Immunosuppression (e.g., HIV/AIDS)
- High parity (multiple full-term pregnancies)
- Infrequent or no screening
Diagnosis[edit | edit source]
- Pap smear – detects precancerous changes
- HPV DNA test – detects high-risk HPV strains
- Colposcopy – magnified cervical examination
- Biopsy – histological confirmation
- Imaging (e.g., MRI, CT, PET) – staging and spread evaluation
Histological Types[edit | edit source]
Common histological types include:
- Squamous cell carcinoma (80–85%)
- Adenocarcinoma (15%)
- Adenosquamous carcinoma
- Small cell carcinoma (neuroendocrine)
Staging[edit | edit source]
Cervical cancer is staged using the FIGO system:
- Stage 0 – Carcinoma in situ
- Stage I – Limited to the cervix
- Stage II – Beyond cervix, not to pelvic wall
- Stage III – Extends to lower vagina/pelvic wall
- Stage IV – Invades bladder/rectum or distant sites
Pathophysiology[edit | edit source]
HPV oncogenes E6 and E7 play central roles:
- E6 inactivates p53, preventing apoptosis
- E7 inhibits retinoblastoma protein (Rb), promoting uncontrolled division
These changes result in cervical intraepithelial neoplasia (CIN), which can progress to invasive cancer.
Prevention[edit | edit source]
- HPV vaccine (e.g., Gardasil, Cervarix)
- Regular Pap smear and HPV testing
- Condom use
- Smoking cessation
- Public health campaigns like Cervical Cancer Awareness Month
Treatment[edit | edit source]
Treatment depends on stage and extent:
Early-stage (Stage 0 & I)[edit | edit source]
- Loop electrosurgical excision procedure (LEEP)
- Cone biopsy
- Hysterectomy (simple or radical)
Locally Advanced (Stage II & III)[edit | edit source]
- Radiotherapy with chemotherapy (cisplatin-based)
- Brachytherapy (internal radiation)
Advanced-stage (Stage IV)[edit | edit source]
- Palliative care
- Targeted therapy (e.g., Bevacizumab)
- Immunotherapy in select patients
Epidemiology[edit | edit source]
- Cervical cancer affects over 500,000 women annually
- High incidence and mortality in low- and middle-income countries
- WHO aims for elimination through vaccination, screening, and treatment
History[edit | edit source]
- Previously linked to sexual activity; rare in celibate women (e.g., nuns)
- Association with HPV confirmed in the 1970s
- HPV vaccine introduced in the 2000s, revolutionizing prevention
Public Health and Awareness[edit | edit source]
- Breast and Cervical Cancer Early Detection Program in the U.S.
- Global efforts like the WHO Cervical Cancer Elimination Strategy
Glossary of Cervical Cancer Terms[edit | edit source]
- Cervarix – Another HPV vaccine, primarily targeting HPV types 16 and 18, used in the prevention of cervical cancer.
- Cervical Cancer Gene Database – A repository of genetic information related to cervical cancer susceptibility and pathogenesis.
- Cervical cancer staging – A classification system, usually based on the FIGO system, that describes the extent of spread of cervical cancer from stage 0 (pre-invasive) to stage IV (metastatic disease).
- Cervical conization – A surgical procedure in which a cone-shaped piece of tissue is removed from the cervix, often to treat or diagnose precancerous conditions.
- Cervical drug delivery – A field of research exploring localized administration of drugs to the cervix to treat or prevent cervical disease.
- Cervical intraepithelial neoplasia – Also known as CIN, it refers to abnormal precancerous changes in the cells of the cervix. It is graded as CIN 1 (mild), CIN 2 (moderate), or CIN 3 (severe).
- Cervical screening – A public health strategy that includes regular Pap tests, HPV testing, and follow-up procedures to detect cervical abnormalities early.
- CervicalCheck cancer scandal – A major public health controversy in Ireland involving misread cervical screening tests and delayed diagnoses.
- Cervicography – A technique in which photographs of the cervix are taken and reviewed by specialists to identify potential precancerous changes.
- Clear-cell adenocarcinoma of the vagina – A rare cancer that has been associated with in utero exposure to diethylstilbestrol (DES); relevant due to its similarities with cervical glandular cancers.
- Colposcopy – A diagnostic procedure using a special microscope to examine the cervix for abnormal areas after a suspicious Pap test.
- Dyskaryosis – An abnormality in the nucleus of cervical cells often seen in Pap smears; considered a sign of potential precancerous change.
- Gardasil – A brand of HPV vaccine that protects against multiple types of human papillomavirus, including those linked to cervical, anal, vulvar, and oropharyngeal cancers.
- Glassy cell carcinoma of the cervix – A rare and aggressive form of cervical cancer with distinct histological appearance and poor prognosis.
- HPV vaccine – A preventive vaccine designed to protect against the most common cancer-causing strains of human papillomavirus, such as types 16 and 18.
- HeLa – An immortal human cell line derived from Henrietta Lacks, a woman with cervical cancer. Widely used in biomedical research.
- Human Papillomavirus (HPV) in Ghana – A topic concerning the prevalence, screening programs, and HPV vaccine access in Ghana.
- Human papillomavirus infection – A sexually transmitted infection that is the primary cause of cervical cancer.
- Koilocyte – An epithelial cell showing cytopathic effects of HPV infection, commonly found in Pap smears of infected individuals.
- Liquid-based cytology – An alternative to the conventional Pap smear where cervical cells are preserved in a liquid medium, improving test accuracy.
- Loop electrical excision procedure – Also called LEEP, this method removes abnormal cervical tissue using a wire loop heated by electric current.
- Neuroendocrine carcinoma of the cervix – A highly aggressive and rare type of cervical malignancy characterized by neuroendocrine features.
- Pap test – Also called a Pap smear, this screening test collects cervical cells to detect precancerous or cancerous changes.
- Papanicolaou stain – A multichromatic staining technique used in the Pap test to highlight cellular details and detect precancerous changes.
- Speculoscopy – A visual inspection technique used to examine the cervix with acetic acid and a blue light to identify abnormal tissue.
- Squamous intraepithelial lesion – A term used in cytology reports to describe changes in squamous cells that may be precancerous. Classified as low-grade (LSIL) or high-grade (HSIL).
- Trachelectomy – A fertility-sparing surgical procedure involving removal of the cervix while preserving the uterus, often performed for early-stage cervical cancer.
- Villoglandular adenocarcinoma of the cervix – A rare variant of cervical adenocarcinoma seen in younger women, often associated with a favorable prognosis.
See Also[edit | edit source]
- HPV vaccine
- Pap smear
- Gynecologic oncology
- Cancer staging
- Oncology
- Colposcopy
- Hysterectomy
- Loop electrical excision procedure
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD